Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Skeith

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Clinical Pharmacokinetics|August 1, 1991
Clinical pharmacokinetics of drugs used in juvenile arthritisK J Skeith, F Jamali
Current Opinion in Rheumatology|June 1, 1992
New horizons in the medical treatment of rheumatoid arthritisK J Skeith, P Davis
The Journal of Rheumatology|March 1, 1988
Adverse reaction to sulfasalazineK J Skeith, A S Russell
Clinical Pharmacokinetics|March 1, 1994
Pharmacokinetic optimisation of the treatment of osteoarthritisK J Skeith, D R Brocks
Drug Safety|March 1, 1994
Differences in NSAID tolerability profiles. Fact or fiction?K J Skeith, M Wright, P Davis
Arthritis and Rheumatism|February 1, 1996
Nonsteroidal antiinflammatory drug-induced enteropathy and severe chronic anemia in a patient with rheumatoid arthritisN M Davies, F Jamali, K J Skeith
Journal of Clinical Pharmacology|November 1, 1993
Ketoprofen pharmacokinetics in the elderly: influence of rheumatic disease, renal function, and doseK J Skeith, A S Russell, F Jamali
The Journal of Rheumatology|October 23, 1997
The use of standardized patients in the performance of a needs assessment and development of a CME intervention in rheumatology for primary care physiciansP Davis, A S Russell, K J Skeith
British Journal of Clinical Pharmacology|August 1, 1996
The influence of renal function on the pharmacokinetics of unchanged and acyl-glucuroconjugated ketoprofen enantiomers after 50 and 100 mg racemic ketoprofenK J Skeith, M Dasgupta, R Lange, et al.
The Journal of Rheumatology|March 1, 1994
Comparative efficacy and toxicity of 10-ethyl-10-deazaaminopterin and methotrexate in a mycobacterial rat arthritis modelK J Skeith, C Ramos-Remus, A S Russell
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical Pharmacokinetics|August 1, 1991
Clinical pharmacokinetics of drugs used in juvenile arthritisK J Skeith, F Jamali
Current Opinion in Rheumatology|June 1, 1992
New horizons in the medical treatment of rheumatoid arthritisK J Skeith, P Davis
The Journal of Rheumatology|March 1, 1988
Adverse reaction to sulfasalazineK J Skeith, A S Russell
Clinical Pharmacokinetics|March 1, 1994
Pharmacokinetic optimisation of the treatment of osteoarthritisK J Skeith, D R Brocks
Drug Safety|March 1, 1994
Differences in NSAID tolerability profiles. Fact or fiction?K J Skeith, M Wright, P Davis
Arthritis and Rheumatism|February 1, 1996
Nonsteroidal antiinflammatory drug-induced enteropathy and severe chronic anemia in a patient with rheumatoid arthritisN M Davies, F Jamali, K J Skeith
Journal of Clinical Pharmacology|November 1, 1993
Ketoprofen pharmacokinetics in the elderly: influence of rheumatic disease, renal function, and doseK J Skeith, A S Russell, F Jamali
The Journal of Rheumatology|October 23, 1997
The use of standardized patients in the performance of a needs assessment and development of a CME intervention in rheumatology for primary care physiciansP Davis, A S Russell, K J Skeith
British Journal of Clinical Pharmacology|August 1, 1996
The influence of renal function on the pharmacokinetics of unchanged and acyl-glucuroconjugated ketoprofen enantiomers after 50 and 100 mg racemic ketoprofenK J Skeith, M Dasgupta, R Lange, et al.
The Journal of Rheumatology|March 1, 1994
Comparative efficacy and toxicity of 10-ethyl-10-deazaaminopterin and methotrexate in a mycobacterial rat arthritis modelK J Skeith, C Ramos-Remus, A S Russell
Pageof 2